Edith A. Perez, M.D., is a world-renowned American translational researcher and cancer specialist, known equally for her impact in designing innovative clinical trials and for her patient-centered humanitarian passion.
Dr. Perez earned her medical degree from the University of Puerto Rico School of Medicine in San Juan and completed her residency in internal medicine at the Loma Linda University Medical Center in California. In addition, she completed her fellowship training at the University of California, Davis. She received additional leadership training from the Wharton School of the University of Pennsylvania, in Philadelphia and the Harvard Executive Development Program at the Harvard Kennedy School, in Boston. Dr. Perez is board certiﬁed in internal medicine, medical oncology and hematology.
Dr. Perez joined Bolt Biotherapeutics in 2020 as its Chief Medical Oﬃcer. She also maintains her academic affiliation as Professor of Medicine with Mayo Clinic and holds leadership roles in various non-profit organizations, including The Donna Foundation and Stand Up to Cancer.